Skip to main content
. 2006 Spring;11(1):11–38. doi: 10.1155/2006/642568

TABLE 13.

Practical tips for prescribing opioids

Opioid-naïve
 Mild to moderate pain Start codeine 30 mg to 60 mg tid (all doses refer to oral route administration)
If a dose of codeine 180 mg/day is inadequate and it is determined that the use of a stronger opioid is necessary, discontinue codeine and replace with a stronger opioid as described below for moderate to severe pain
Moderate to severe pain
 Option 1 Start continuous-release morphine 10 mg to 15 mg q12h with regular morphine 5 mg q4h prn for breakthrough pain control up to three doses per 24 h as a start
 Option 2 It is also reasonable to start with a short-acting form of a stronger opioid such as morphine sulphate 5 mg, oxycodone 2.5 mg to 5 mg or Percocet* first and then transfer to a continuous release form once the initial dose requirement is established
Titrate dose every three to five days according to analgesic requirements and limiting side effects
Patient already on an opioid with moderate to severe pain and poor pain control Initiate a trial of increased dose, titrating in increments appropriate to the agent and the dose until adequate pain relief or limiting side effects are encountered
Reasonable dose increments in mg (start with q12h dosing; occasionally, more frequent dosing may be required, eg, q8h or q6h); morphine continuous release: 15, 30, 60, 75, 90, 120,150,180, 200, 230, 260; oxycodone continuous release: 10, 20, 30, 40, 50, 60, 70, 80, 100, 120, 140; hydromorphone continuous release: 3, 6, 12, 18, 24, 30, 36, 42, 48, 54, 60
Duragesic (in μg/h) : 25, 50, 75, 100, 125, 150, 175, 200
If one agent fails, one may switch to an equivalent dose of another agent. If two different opioid agents provide inadequate relief or limiting side effects then one may consider a trial of methadone

Please see Figure 1 as well for the use of coanalgesics. Please refer to Table 11 for guidelines to assist in deciding whether a trial of chronic opioid is appropriate.

*

Endo Pharmaceuticals Inc, USA. prn As needed; q Every; tabs Tablets; tid Three times daily